Removing ovarian antigens before the immune system detects them does not stop the production of certain autoantibodies, suggesting that similar antigens present outside the ovaries can trigger this response.

8

Pro

0

Against

Evidence from Studies

Supporting (1)

8

Community contributions welcome

8

Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.

Case-Control Study

Animal

Even when scientists removed the ovaries before the immune system started reacting, the body still made antibodies against ZP3—meaning the antibodies must have been triggered by ZP3 hiding somewhere else in the body, not just in the ovaries.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.

Score: 8

DOI: 10.4049/jimmunol.156.9.3535

Similar Assertions

Certain immune system responses to non-ovarian peptides that resemble ZP3 can lead to the production of antibodies against ZP3, which may contribute to autoimmune reactions.

8

0

77%

After immunization, antibodies targeting the ZP3 protein appear by day 7, before antibodies against a related T cell peptide are detected, showing that the immune system generates a specific type of fast-acting antibody response.

8

0

73%